Sperm may play leading role in spreading HIV

	Tweet

Sperm, and not just the fluid it bathes in, can transmit HIV to macrophages, T cells, and dendritic cells (DCs), report a team led by Ana Ceballos at the University of Buenos Aires in Argentina. By infecting DCs, which carry the virus and potently pass it to T cells, sperm may play a leading role in spreading HIV. The article appears in the November 23, 2009 issue of the Journal of Experimental Medicine (online October 26).

During sexual intercourse, HIV-infected men transmit HIV through their semen, which carries free-floating virus as well as HIV-infected leukocytes. Traces of HIV have been detected on sperm as well, but the role they play in viral transmission has been a matter of debate. After all, men with vasectomies can transmit HIV. Now, Ceballos et al. show that HIV attaches to the surface of sperm and that these HIV carriers pass on the virus to DCs and other HIV targets.

Sperm express molecules known to interact with HIV’s envelope, such as heparan sulfate and mannose receptors. The authors show that HIV relies on heparan sulfate to attach to sperm, but not mannose receptors as previously predicted.

Once attached, the virus was transmitted from sperm to DCs in culture. The DC receptors CD4 and DC-SIGN were required for transmission, suggesting that DCs pick up the virus by binding to sperm rather than by ingesting them. DCs matured after interacting with the sperm, producing tolerance-promoting cytokines like interleukin-10. The authors speculate that this immune-suppressing profile, versus an inflammatory profile, might also help the virus spread.

Sperm might reach DCs by passing through microabrasions in the vaginal or anal lining that often form during intercourse, suggest the authors. Or they might contact the finger-like projections of DCs that extend to the surface of mucosal linings. Furthermore, the team found that a slightly acidic pH, similar to the pH in the vagina after sex, promoted HIV–sperm binding and the subsequent rate of sperm-related DC infection.

###

About the The Journal of Experimental Medicine

The Journal of Experimental Medicine (JEM) is published by the Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JEM content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit http://www.jem.org.

Ceballos, A., et al. 2009. J. Exp. Med. doi:10.1084/jem.20091579.

Contact: Rita Sullivan

212-327-8603
Rockefeller University Press

RELATED STORIES:
Indiana University Scientist Works to Detach Protein that HIV Uses as Protective Shield   New HIV-vaccine tested on people   New Research Reveals How Protein Protects Cells From HIV Infection   AIDS Prevention Inspires Ways to Make Circumcisions Easier   Bill Gates injects $750 million into troubled AIDS fund   Having a Dog or Cat Helps Women Cope with HIV/AIDS   Saliva HIV test passes the grade   Caution Needed When Choosing Seizure Drugs for People with HIV/AIDS   Drug to Treat HIV in Children Shows Promise Via National Clinical Trial   Study in monkeys raises hope for HIV vaccines   Pathogenic Landscape Of HIV   Bali HIV scare fuels concern over tattoo safety

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]